skip to primary navigationskip to content
 

Cambridge New Therapeutics Forum (CamNTF)

When Sep 19, 2016
from 05:30 PM to 08:00 PM
Where EMBL-European Bioinformatics, Institute, Wellcome Genome Campus, Hinxton, CB10 1SD
Add event to calendar vCal
iCal

Cambridge New Therapeutics Forum (CamNTF) promotes interactions between scientists at these organisations in order to improve opportunities for biotechnology research and development and is a scientific forum open to all scientists interested in research and development of new therapeutics in Cambridge and the local area, including scientists at the University, Addenbrooke’s Hospital, pharmaceutical companies, biotechs, CROs, and not-for-profit organisations.

Launched in 2015, CamNTF hosts early-evening meetings open to all scientists interested in research into new therapeutics. These rotate around different organisations located in the Cambridge biotech cluster. Each two-hour session will begin with short scientific presentations and will be followed by networking and snacks (6pm-8pm). 

Attendance is free but all attendees must register in advance.  Places are limited and early registration will be important to avoid disappointment! Registration closes one week prior to the meeting.

Please register here and click here for the flyer.

OPdA Tweets

Upcoming events

CEGX: The spinout that’s measuring the epigenome to improve human health

Sep 12, 2017

Pfizer Lecture Theatre, Department of Chemistry, Lensfield Road

Pitching Training Event

Sep 15, 2017

Seminar Room B, 17 Mill Lane

Upcoming events

RSS Feed Latest news

Grants available through the Returning Carers Scheme - apply by 29 September

Aug 16, 2017

The Returning Carers Scheme provides funds to support career development following a career break or a period of leave for caring responsibilities.

Opportunity to apply for up to £30,000 funding from the EPSRC: apply by 16 August

Aug 08, 2017

Postdocs are invited to apply via the OPdA for funding for activities which fall under the remit of the EPSRC and the Global Challenges Research Fund.

View all news